Coagulant Therapeutics Announces Upcoming Oral and Poster Presentations at the 2022 American Society of Hematology (ASH) Annual Meeting

/PRNewswire/ -- Coagulant Therapeutics Corporation, a privately held company focused on the design, development and commercialization of therapeutics targeted...

Related Keywords

Berkeley ,California ,United States ,Louisiana ,New Orleans ,American ,Derek Sim ,Eliza Schleifstein ,American Society Of Hematology ,Nanobody Library ,Coagulant Therapeutics Corporation ,Antibody Program ,American Society ,Annual Meeting ,Selective Modulation ,Activated Proteinc Activities ,Exosite Specific Nanobody ,Rapid Clearing Factor ,Provides Pro Hemostatic Activity ,Reduce Blood Loss ,Coagulopathic Conditions Induced ,Activated Protein ,Vice President ,